Use cautionDrug recall · FDA · Published October 27, 2017
Fresenius Kabi Midazolam Syringes Recalled Due to Label Mix-Up
Fresenius Kabi recalls 24-pack midazolam injection syringes that are mislabeled with ondansetron instead. This mix-up could lead to incorrect medication use. Consumers should check their syringes and contact the company for details.
“Fresenius Kabi Midazolam Syringes Recalled Due to Label Mix-Up.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/41117-fresenius-kabi-midazolam-syringes-recalled-due-to-label-mix-up. Based on FDA recall #D-0152-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0152-2018%22&limit=1).
Fresenius Kabi USA, LLC voluntarily recalled Midazolam Injection, USP, Preservative Free, 2 mg / 2 mL prefilled syringes due to a labeling mix-up hazard, according to the FDA. The agency announced the recall on October 27, 2017.
How to tell if you have it
Brand: Fresenius Kabi
Product: Midazolam Injection, USP, Preservative Free, 2 mg / 2 mL (1 mg / mL), 24 X 2mL Prefilled single-use syringes per carton
NDC: 76045-001-20
Lot code: 6400048
The hazard
The blister packages labeled as Midazolam injection, USP, 2 mg / 2 ml contained syringes of Ondansetron Injection, USP, 4 mg / 2 mL. This labeling mix-up poses a risk of incorrect medication administration.
Context
GovInfoNow's records show Fresenius Kabi USA, LLC has 65 other recalls on record since September 27, 2012. Other recent recalls include the Fresenius Kabi Tyenne Injection recall for glass particles (August 10, 2026), the Fresen Morphine Syringes labeling error (August 4, 2026), and the Fresenius Kabi Xylocaine 1% Injection hair particulate hazard (July 16, 2026). Other recent recalls of similar products include the Ajanta Pharma Aripiprazole Tablets mix-up risk (May 27, 2026), the American Health Packaging Buprenorphine Tablets label mix-up (August 19, 2026), and the Annora Pharma Lacosamide Tablets possible Selexipag mix-up (June 4, 2026).
How to tell if you have this one
Check for blister packs labeled as 'Midazolam injection, USP, 2 mg / 2 ml' that contain syringes of ondansetron. The product was sold with NDC 76045-001-20 and lot number 6400048.
Brand
Fresenius Kabi
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Syringe Label
Look for blister packs labeled as Midazolam injection, USP, 2 mg / 2 ml that contain ondansetron syringes instead.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.9 years after the firm started it.
1Firm started the recall
2FDA classified it Class I
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0152-2018 (October 27, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0152-2018 to see it in context.
Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.